Mediplus Pharma

Mediplus Pharma is a Japan-based healthcare and pharmaceutical-related company developing, manufacturing, and marketing pharmaceuticals, quasi-pharmaceutical products, cosmetics, and related oral-care and pet-care products. The company is best known for its proprietary ozonized glycerin technology, a patented ozone-derived ingredient platform that it applies across skincare, oral care, and biomaterials-oriented research. Mediplus has commercialized products including skincare cosmetics, dental-use ozonated paste, and pet-care offerings, while also pursuing development programs in veterinary health such as mastitis treatment for dairy cows and oral hygiene applications for dogs. The business appears to operate as a private, active company with in-house R&D and manufacturing capabilities in Japan. Its profile is closer to a specialty pharma/cosmeceutical and animal-health innovator than to a traditional clinical-stage biotech focused on human prescription therapeutics.